17 min listen
Rivaroxaban Pharmacology
FromReal Life Pharmacology - Pharmacology Education for Health Care Professionals
Rivaroxaban Pharmacology
FromReal Life Pharmacology - Pharmacology Education for Health Care Professionals
ratings:
Length:
17 minutes
Released:
Apr 18, 2019
Format:
Podcast episode
Description
Rivaroxaban is a factor 10a inhibitor that inhibits clot formation and thins the blood.
Rivaroxaban needs to be monitored for bleed risk. Checking periodic CBC can help us assess if hemoglobin and hematocrit are remaining stable.
Enzyme inducers like rifampin, St. John's Wort, and carbamazepine can reduce concentrations and increase the risk of treatment failure.
NSAIDs and antiplatelet medications can significantly increase the risk of bleed with rivaroxaban.
Rivaroxaban should not be used with dual P-glycoprotein and CYP3A4 inhibitors. Examples include ketoconazole, itraconazole, and ritonavir.
Rivaroxaban needs to be monitored for bleed risk. Checking periodic CBC can help us assess if hemoglobin and hematocrit are remaining stable.
Enzyme inducers like rifampin, St. John's Wort, and carbamazepine can reduce concentrations and increase the risk of treatment failure.
NSAIDs and antiplatelet medications can significantly increase the risk of bleed with rivaroxaban.
Rivaroxaban should not be used with dual P-glycoprotein and CYP3A4 inhibitors. Examples include ketoconazole, itraconazole, and ritonavir.
Released:
Apr 18, 2019
Format:
Podcast episode
Titles in the series (100)
Statin Pharmacology Episode 005: In this episode, I talk about the most commonly used statins. In my practice I see simvastatin, atorvastatin, rosuvastatin, and pravastatin used most frequent. In addition, I also discuss why statins are dosed at night, possible side effects, by Real Life Pharmacology - Pharmacology Education for Health Care Professionals